Podcast thumbnail for An Arm and a Leg

An Arm and a Leg

Claim This Podcast

by An Arm and a Leg

4.8(1,173 reviews)
165 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
79

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality74
Social90
YouTube68
Engagement98

Podcast Overview

<p>An Arm and a Leg&nbsp;is a podcast about why health care costs so freaking much and what we can (maybe) do about it.</p> <p>If you&rsquo;ve ever been surprised by a medical bill, you&rsquo;re in good company. But as our team of seasoned journalists has learned from years of reporting &mdash; you&rsquo;re not always helpless. We don&rsquo;t have all the answers, but we&rsquo;ll offer you tools and big picture insights with plenty of humor and heart.&nbsp;</p> <p>An Arm and a Leg is co-produced with <a href="https://kffhealthnews.org/">KFF Health News</a> and distributed in partnership with <a href="https://www.kuow.org/">KUOW</a>.</p> <p>You can support An Arm and a Leg&nbsp;by donating at <a href="https://armandalegshow.com/support/">armandalegshow.com/support/</a></p> <hr> <p><strong>Show Credits:&nbsp;</strong>Created, hosted, and produced by Dan Weissmann with senior producer Emily Pisacreta and engagement producer Claire Davenport, edited by Ellen Weiss. Audio wizard: Adam Raymonda. Music is by Dave Weiner and Blue Dot Sessions. Bea Bosco is our consulting director of operations. Lynne Johnson is our operations manager.</p>

Language

🇺🇲

Publishing Since

10/11/2018

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

79

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality74
Social90
YouTube68
Engagement98
9
Excellent Areas
1
Good Performance
9
Growth Opportunities
excellent
Episode Length
25 minutes
Performing excellently!
good
iTunes Tags
6.5/10

Recommendations available

Unlock the full report to see detailed tips

needs improvement
Publishing Consistency
Every 17 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for An Arm and a Leg

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for The Chatbot Will See You Now: Big Tech In Therapy (from Organized Money)

May 21, 2026

The Chatbot Will See You Now: Big Tech In Therapy (from Organized Money)

Host Dan Kois interviews psychologist Linda Michaels about tech companies recording therapy sessions and how Illinois's new law offers a path to better mental healthcare access.

Episode thumbnail for The Supreme Court case that could slow generic drugs

April 27, 2026

The Supreme Court case that could slow generic drugs

<p>It&rsquo;s a case you&rsquo;ve (probably) never heard of: This week, the Supreme Court is hearing <a href="https://www.supremecourt.gov/oral_arguments/argument_audio/2025">oral arguments</a> in Hikma v. Amarin &mdash; a legal battle that could impact how much you ultimately pay for prescription drugs.&nbsp;</p> <p>Here&rsquo;s why the case matters: As soon as a generic version of a brand-name drug comes to market, its price typically drops by half. Within 10 years, by more than 75%. Meaning: the sooner we have access to generics, the less we pay at the pharmacy counter.&nbsp;</p> <p>But one of the fastest legal pathways for generic companies to get their drugs to market may be about to get a lot narrower &ndash; depending on how the court rules later this year.</p> <p>Amarin, a brand-name drugmaker, has accused Hikma, a generic company, of encouraging doctors to infringe on their patent for a drug called Vascepa.&nbsp;&nbsp;</p> <p>The case revolves around the legal concept of skinny labels: a carveout in drug patent law that allows generic companies to bring drugs to market when one of the brand-name drug&rsquo;s patents has expired, but others haven&rsquo;t.</p> <p>And it raises the (unexpected) question of whether it&rsquo;s OK for a generic drug company to call their product the&nbsp;generic version of something.&nbsp;</p> <p>Legal experts help us unpack the nerdy details &ndash; including how this case came to be, and what&rsquo;s at stake for both generic drug companies and anyone looking forward to one day paying less for an expensive brand-name drug.&nbsp;</p> <p>Want to learn how these drug monopolies work &ndash; and came to be in the first place? Check out our previous episode: <a href="https://armandalegshow.com/episode/medicine-monopolies-101/">Why drugs cost so much, 101: Medicine monopolies</a></p> <p><a href="https://armandalegshow.com/episode/the-supreme-court-generic-drugs/#transcript">Here's a copy of this episode's transcript</a>.&nbsp;</p> <p><a href="https://armandalegshow.com/contact/">Send your stories and questions.</a> Or call 724 ARM-N-LEG.</p> <p>And of course we&rsquo;d love for you to<a href="https://armandalegshow.com/support/"> support this show</a>.</p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

Episode thumbnail for Why drugs cost so much, 101: Medicine monopolies

April 9, 2026

Why drugs cost so much, 101: Medicine monopolies

<p>We&rsquo;re always asking: Why do drugs cost so freaking much?&nbsp;</p> <p>And it&rsquo;s a complicated question. There are a bunch of reasons &mdash;&nbsp;<a href="https://armandalegshow.com/episode/pbms-2023/">to</a> <a href="https://armandalegshow.com/first-aid-kit/why-drugs-cost-so-much-and-can-be-hard-to-even-find/">be</a> <a href="https://armandalegshow.com/episode/swimming-with-sharks/">sure</a>. But in our reporting over the years, like our stories on <a href="https://armandalegshow.com/episode/the-insane-surprising-history-behind-insulins-crazy-price-and-some-hopeful-signs-in-the-wild/">insulin</a> and <a href="https://armandalegshow.com/episode/john-green-part-1/">tuberculosis drugs</a>, experts cited one big reason over and over again:&nbsp;</p> <p>The pharmaceutical industry wages sophisticated legal battles to keep monopoly control over their best selling, most lucrative drugs &mdash; blocking generic competition, and increasing their prices along the way.&nbsp;</p> <p>How did it come to be this way?&nbsp;</p> <p>In this first episode of a new series &ndash; what we&rsquo;re calling An Arm and a Leg 101 &ndash; we&rsquo;re doing a crash course in the history of the drug patent system.</p> <p>And the rags-to-riches story of one amazing guy is going to help us do it.&nbsp;</p> <p>Al Engelberg got schooled in the Art of the Hustle at a young age, collecting dimes at an illegal bingo game on the Atlantic City boardwalk.&nbsp;</p> <p>Later, he&rsquo;d put those street smarts to use as he sat at the negotiation table in Washington D.C., hashing out the details of a law that would usher in the generic drug industry as we know it. Then made millions from the rules he helped write.</p> <p>And as he admits, his legacy is mixed.&nbsp;</p> <p>On the one hand: The rules Al Engelberg helped write &mdash; a grand bargain between generic drugmakers and patent-holding brand pharma companies&mdash; unleashed the power of generic drugs to save Americans money.&nbsp;</p> <p>Nine out of ten prescriptions written today get filled with a generic.</p> <p>On the other hand: In the process of making his fortune, Al Engelberg discovered loopholes, gaps, and perverse incentives in that grand bargain.&nbsp;</p> <p>Gaps that allowed brand and generic drugmakers to profit by keeping generics for many hit drugs off the market.&nbsp;&nbsp;</p> <p>So we now spend more than ever on medicine &mdash; and more than 20 percent of Americans report skipping their medication because they can&rsquo;t afford it.&nbsp;</p> <p>Al Engelberg, now 86, has spent the last 30 years &mdash; and millions of his own dollars &mdash; trying to close those gaps.&nbsp;</p> <p>&ldquo;I live in a world &mdash; a pharma world &mdash; where half the people think I&rsquo;m dead, and the other half wish I was,&rdquo; he tells us.&nbsp;</p> <p>You can read more of Al&rsquo;s story &mdash; plus his prescription for fixing the crisis of high drug prices &mdash; in his book, <a href="https://www.simonandschuster.com/books/Breaking-the-Medicine-Monopolies/Alfred-Engelberg/9798888456729">Breaking the Medicine Monopolies: Reflections of a Generic Drug Pioneer</a>.</p> <p>And you can hear our earlier reporting on drug patents here:</p> <p><a href="https://armandalegshow.com/episode/john-green-part-1/">John Green vs. Johnson &amp; Johnson (part 1)</a></p> <p><a href="https://armandalegshow.com/episode/john-green-vs-j-and-j-part-2/">John Green vs. Johnson &amp; Johnson (part 2)</a></p> <p><a href="https://armandalegshow.com/episode/the-insane-surprising-history-behind-insulins-crazy-price-and-some-hopeful-signs-in-the-wild/">The surprising history behind insulin's absurd price (and some hopeful signs in the wild)</a></p> <p><a href="https://armandalegshow.com/episode/medicine-monopolies-101/#transcript">Here's a copy of this episode's transcript.&nbsp;</a></p> <p><a href="https://armandalegshow.com/contact/">Send your stories and questions.</a>&nbsp;Or call 724 ARM-N-LEG.</p> <p>And of course we&rsquo;d love for you to<a href="https://armandalegshow.com/support/">&nbsp;support this show</a>.</p> <p><strong>An Arm and a Leg 101 is made possible in part by support from Arnold Ventures.</strong></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>

165 total episodes available with 44 transcripts

Recent guests on An Arm and a Leg

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Linda Michaels

Guest

Nicole Wipp

Guest

Noah Hulsman

Guest

Renuka Rayasam

Guest

Thomas Goetz

Guest

Zach Mider

Guest

Zeke Faux

Guest

David Dayen

Guest

Matt Stoller

Guest

Bob

Guest

Eugene Litvak

Guest

Julie Rovner

Guest

Deep-dive analytics for An Arm and a Leg

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is An Arm and a Leg?
<p>An Arm and a Leg&nbsp;is a podcast about why health care costs so freaking much and what we can (maybe) do about it.</p> <p>If you&rsquo;ve ever been surprised by a medical bill, you&rsquo;re in good company. But as our team of seasoned journalists has learned from years of reporting &mdash; you&rsquo;re not always helpless. We don&rsquo;t have all the answers, but we&rsquo;ll offer you tools and big picture insights with plenty of humor and heart.&nbsp;</p> <p>An Arm and a Leg is co-produced with <a href="https://kffhealthnews.org/">KFF Health News</a> and distributed in partnership with <a href="https://www.kuow.org/">KUOW</a>.</p> <p>You can support An Arm and a Leg&nbsp;by donating at <a href="https://armandalegshow.com/support/">armandalegshow.com/support/</a></p> <hr> <p><strong>Show Credits:&nbsp;</strong>Created, hosted, and produced by Dan Weissmann with senior producer Emily Pisacreta and engagement producer Claire Davenport, edited by Ellen Weiss. Audio wizard: Adam Raymonda. Music is by Dave Weiner and Blue Dot Sessions. Bea Bosco is our consulting director of operations. Lynne Johnson is our operations manager.</p>
How often does this podcast release new episodes?

This podcast updates weekly.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.